Trial intelligence / Profile preview

Longjintonglin Capsules for Chronic Prostatitis with Lower Urinary Tract Symptoms or Chronic Pelvic Pain Syndrome

ChiCTR2500107957Phase 4Not yet recruiting

Sponsor
Hangzhou Third People's Hospital
Start
Aug 2025
Countries
1
01

Overview

Phase 4 trial of Longjintonglin Capsules in chronic prostatitis (CP) and Micturition disorder (2 arms), sponsored by Hangzhou Third People's Hospital. Primary endpoint: NIH-CPSI score at week 12. Planned start Aug 2025; status: not yet recruiting.

02

Drugs

Longjintonglin Capsules
03

Conditions

chronic prostatitis (CP)Micturition disorder

Beyond the preview

Go deeper on ChiCTR2500107957.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500107957.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call